Atlas Trials

Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease

Clinical trial NCT05297812 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05297812
Sponsor
Columbia University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Alpha 1-Antitrypsin DeficiencyGenetic Disease
Start date
2022-03-23
Primary completion
2027-01-01
Enrollment
286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.